XBI

State Street SPDR S&P Biotech E (XBI)
• • $154.26 • MCap: 0 🌐
• In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Buy Decision Core
Total Score
30
Business Quality
1
Financial Strength
6
Growth Outlook
1
Momentum
4
Price Action
Current
154.26
52W High
164.28
52W Low
84.77
Above 50DMA
141.84 (8.76%)
Above 200DMA
126.46 (21.98%)
Relative Strength
Relative Strength
0.36
RS 3M
0.14
RS 6M
0.22
RS 9M
0.47
RS 12M
0.8
Fundamentals
Revenue Growth
0%
Earnings Growth
0%
ROE
0%
ROA
0%
Valuation
PE (Fwd)
0
PEG
0
P/B
0
Upside
0%
Risk
Beta
0
Short %
0
Risk Score
0
Analyst
Rating
Target
0
Beta
0
Analysts
0
Total Score
30
Upside
0%
Relative Strength
0.36
Beta
0
Why Buy?
  • PEG Ratio below 1 (attractive valuation)
  • Trading below book value
  • Trading above 50 DMA
  • Trading above 200 DMA
Key Risks
Score Breakdown
Business
1
Financial
6
Growth
1
Valuation
12
Risk
5
Momentum
4
Technical
52W High: 164.28
52W Low: 84.77
Above 50DMA: 8.76%
Above 200DMA: 21.98%
Valuation
Forward PE: 0
PEG: 0
P/B: 0
Upside: 0%
Risk
Beta: 0
Short Float: 0%
ROE: 0%
ROA: 0%